Enhanced Efficacy of Tumor Cell Vaccines Transfected With Secretable Hsp70

Cancer Research - United States
doi 10.1158/0008-5472.can-03-2936
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Allogeneic Tumor Cell Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted With Immunopotentiators in Chickens

Frontiers in Microbiology
Microbiology
2017English

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Tumor-Mediated Suppression of Dendritic Cell Vaccines

2004English

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Human HSP70 and Modified HPV16 E7 Fusion DNA Vaccine Induces Enhanced Specific CD8+ T Cell Responses and Anti-Tumor Effects

Oncology Reports
MedicineCancer ResearchOncology
2009English

Enhanced Efficacy and Limited Systemic Cytokine Exposure With Membrane-Anchored Interleukin-12 T-Cell Therapy in Murine Tumor Models

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Delivery of Interferon-Α Transfected Dendritic Cells Into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines

Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy